Bristol-Myers Squibb Company (BMY), headquartered in New York and with a market cap of $121.6 billion, is a global leader in ...
Shares of Bristol Myers Squibb Co. BMY slumped 0.55% to $58.37 Wednesday, on what proved to be an all-around great trading ...
Low- and middle-income countries (LMICs) are undergoing a significant health transformation. While once predominantly ...
BMS has been among the pharma giants that have bought into AI for drug discovery. In 2021, the company struck a $1.2 billion ...
Bristol Myers Squibb Co. closed $2.39 below its 52-week high ($61.08), which the company reached on November 11th.
Bristol Myers Squibb (BMY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the ...
Bristol-Myers Squibb (NYSE: BMY) is the kind of stock that potentially has a lot to offer to investors looking for ...
Bristol Myers Squibb became the latest large drugmaker to sue the federal government over a plan to change how it doles out ...
It's been a challenging past few years for Bristol Myers Squibb (NYSE: BMY). The company's financial results dipped following ...
The moves will affect more than 300 employees across both companies as both firms look to drive growth in the long term.
Finding attractive dividend stocks you can hold isn't too difficult. Finding dividend stocks you can comfortably buy and hold ...
AI Proteins, Inc., a biotechnology company that utilizes computational de novo protein design to create therapeutic miniproteins, today announced that it has entered a Research Collaboration and ...